The retail cost of Xiidra (lifitegrast ophthalmic solution) 5% can vary, but it is often priced around \$570 for a 30-day supply [1]. Factors such as insurance coverage, pharmacy location, and available discounts can influence the final out-of-pocket expense for patients [1].
How can I lower the cost of Xiidra?
Patients may be able to reduce their Xiidra costs through several avenues. The manufacturer, Takeda Pharmaceuticals, offers a savings program for eligible commercially insured patients, which can lower the monthly cost to as little as \$20 [2][3]. This program has specific eligibility requirements and limitations [2][3]. Additionally, exploring generic alternatives, if and when they become available, could present a more affordable option, though currently, there are no FDA-approved generic versions of Xiidra [4]. Comparing prices across different pharmacies and discussing cost-saving options with a healthcare provider are also recommended steps [1].
When does Xiidra's patent expire?
The primary patents for Xiidra are set to expire around 2035 [5]. DrugPatentWatch.com tracks patent expiry dates for various medications, including Xiidra [5]. The specific expiration dates can be complex and depend on different patent types and any potential extensions.
Can generic Xiidra be made before patent expiration?
Generally, generic versions of a drug cannot be legally manufactured and marketed in the United States until the relevant patents and exclusivities expire [6]. Once these protections are no longer in effect, other pharmaceutical companies can seek approval from the U.S. Food and Drug Administration (FDA) to produce and sell generic equivalents [6].
What is Xiidra used for?
Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease [7]. It works by reducing inflammation that is associated with dry eye [7].
How effective is Xiidra for dry eye disease?
Clinical studies have shown that Xiidra can help improve both the signs and symptoms of dry eye disease. In trials, patients using Xiidra experienced a reduction in ocular discomfort and an improvement in tear production [7].
What are the side effects of Xiidra?
The most common side effects reported with Xiidra include eye irritation, pain, and changes in taste perception [7]. Less frequent side effects may also occur. Patients should discuss any concerns about potential side effects with their eye doctor [7].
How does Xiidra compare to other dry eye treatments?
Xiidra is a prescription medication that targets inflammation, a key component of dry eye disease. Other treatments for dry eye can include artificial tears, punctal plugs, and other prescription medications with different mechanisms of action [8]. The choice of treatment often depends on the severity and underlying cause of the dry eye condition.
Who makes Xiidra?
Xiidra is manufactured by Takeda Pharmaceuticals [2].
---
Cited Sources:
1. https://www.drugpatentwatch.com/drug/xiidra
2. https://www.takeda.com/en-us/patients-and-communities/patient-support/
3. https://www.xiidra.com/savings-and-support/
4. https://www.accessdata.fda.gov/scripts/drugObatinf/
5. https://www.drugpatentwatch.com/
6. https://www.fda.gov/drugs/types-generic-drugs
7. https://www.xiidra.com/
8. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/dry-eye